Takanori Teshima | GvHD Hub
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT | Blood Cancer Journal
Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party | Bone Marrow Transplantation
Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome | Bone Marrow Transplantation
EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment | Bone Marrow Transplantation
Biology of Blood and Marrow Transplantation | Abstracts from the 2016 BMT Tandem Meetings | ScienceDirect.com by Elsevier
GvHD Hub on Twitter: "#GvHDSummit Takanori Teshima, MD: Restoration of gut microbial ecology @TheEBMT #GvHD #gvhdsm #microbiota https://t.co/My6tHTP4bT" / Twitter
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies | Request PDF
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation | NEJM
Organization :: APBMT
1st EBMT GVHD Summit | EBMT
1st EBMT GVHD Summit | EBMT
1st EBMT GVHD Summit | EBMT
Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups | Haematologica
Flow diagram of patients enrolled in the EBMT PASS PASS... | Download Scientific Diagram
Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society ...
Takanori Teshima | EBMT 2019 | Treatment options for patients with steroid-refractory aGvHD
Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in Japan | SpringerLink
Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antithymocyte Globulin in Peripheral Blood Stem Cell Transplantation—A Matched-Pair Analysis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation ...
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular ...
Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ...
PDF) HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning
PDF) Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
Volume 57 Issue 12, December 2022
